ARCHIVES

FDA Grants Priority Review To Two Drugs in NSCLC

This article is from The Cancer Letter archive.

Vol. 36 No. 2 | February 22, 2013

Download PDF Visit The Full Archive

Related Articles

Diptheria Toxin Prompts Immune System To Kill Cancer

December 29, 2006

Information Lacking On Use, Accuracy Of HER2 Tests

September 25, 2009

NCI, NCAB o Seek $1.036 billion In ’79; Senate Committee Approves $920 Million for Fiscal ‘78

June 3, 1977

Weekly Paclitaxel, Carboplatin Safer For Advanced Lung Cancer, Study Finds

August 31, 2001

Ilex Oncology Buys Symphar, Controls Drug For Bone Mets.

March 2, 2001

Hospital to Review Medenica’s Privileges, With Conditions

November 5, 1993